Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Phase II study of HSK36273 for systemic anticoagulation in CRRT
CTR20222639Phase 2Active
- Sponsor
- Haisco Pharmaceutical Group Co., Ltd.
- Start
- Nov 2022
- Modality
- Small Molecules
- Countries
- 1
01
Overview
A Phase 2 trial of frunexian in kidney failure, None, sponsored by Haisco Pharmaceutical Group Co., Ltd.. Started Nov 2022; status: active.
02
Drugs
frunexian
03
Conditions
kidney failure
Beyond the preview
Go deeper on CTR20222639.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on CTR20222639.